Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Liposomal Drug Delivery Systems and Anticancer Drugs.

Olusanya TOB, Haj Ahmad RR, Ibegbu DM, Smith JR, Elkordy AA.

Molecules. 2018 Apr 14;23(4). pii: E907. doi: 10.3390/molecules23040907. Review.

2.

Insights into the Influences of Carboxymethyl-β-Cyclodextrin on DNA Formulations Characteristics and Gene Transfection Efficiency.

Elsana H, Mysina S, Elkordy EA, Carr-Wilkinson J, Elkordy AA.

Curr Drug Deliv. 2018;15(6):867-878. doi: 10.2174/1567201815666180226115503.

PMID:
29484997
3.
4.

Naproxen Microparticulate Systems Prepared Using In Situ Crystallisation and Freeze-Drying Techniques.

Solaiman A, Tatari AK, Elkordy AA.

AAPS PharmSciTech. 2017 Jul;18(5):1438-1446. doi: 10.1208/s12249-016-0682-0. Epub 2016 Dec 21.

PMID:
28004343
5.

Influences of copolymers (Copovidone, Eudragit RL PO and Kollicoat MAE 30 DP) on stability and bioactivity of spray-dried and freeze-dried lysozyme.

Haj-Ahmad RR, Mamayusupov M, Elkordy EA, Elkordy AA.

Drug Dev Ind Pharm. 2016 Dec;42(12):2086-2096. Epub 2016 Jun 26.

PMID:
27297093
6.

Application of general multilevel factorial design with formulation of fast disintegrating tablets containing croscaremellose sodium and Disintequick MCC-25.

Solaiman A, Suliman AS, Shinde S, Naz S, Elkordy AA.

Int J Pharm. 2016 Mar 30;501(1-2):87-95. doi: 10.1016/j.ijpharm.2016.01.065. Epub 2016 Jan 28.

PMID:
26827922
7.

Formulation and advantages of furazolidone in liposomal drug delivery systems.

Alam MI, Paget T, Elkordy AA.

Eur J Pharm Sci. 2016 Mar 10;84:139-45. doi: 10.1016/j.ejps.2016.01.017. Epub 2016 Jan 18.

PMID:
26796143
8.

In vitro characterisation of Span 65 niosomal formulations containing proteins.

Haj-Ahmad RR, Elkordy AA, Chaw CS.

Curr Drug Deliv. 2015;12(5):628-39.

PMID:
25963305
9.

Design and evaluation of effervescent floating tablets based on hydroxyethyl cellulose and sodium alginate using pentoxifylline as a model drug.

Rahim SA, Carter PA, Elkordy AA.

Drug Des Devel Ther. 2015 Mar 31;9:1843-57. doi: 10.2147/DDDT.S78717. eCollection 2015.

10.

Compare and contrast the effects of surfactants (PluronicF-127 and CremophorEL) and sugars (β-cyclodextrin and inulin) on properties of spray dried and crystallised lysozyme.

Haj-Ahmad RR, Elkordy AA, Chaw CS, Moore A.

Eur J Pharm Sci. 2013 Jul 16;49(4):519-34. doi: 10.1016/j.ejps.2013.05.004. Epub 2013 May 25.

PMID:
23712374
11.

In situ lyophilisation of nifedipine directly in hard gelatine capsules.

Crum M, Elkordy AA, Zarara M, Elkordy EA.

Pharm Dev Technol. 2013 Nov-Dec;18(6):1379-90. doi: 10.3109/10837450.2012.723718. Epub 2012 Sep 20.

PMID:
22992055
12.

Spironolactone release from liquisolid formulations prepared with Capryol™ 90, Solutol® HS-15 and Kollicoat® SR 30 D as non-volatile liquid vehicles.

Elkordy AA, Tan XN, Essa EA.

Eur J Pharm Biopharm. 2013 Feb;83(2):203-23. doi: 10.1016/j.ejpb.2012.08.004. Epub 2012 Aug 30.

PMID:
22960707
13.

Liquisolid technique to enhance and to sustain griseofulvin dissolution: effect of choice of non-volatile liquid vehicles.

Elkordy AA, Essa EA, Dhuppad S, Jammigumpula P.

Int J Pharm. 2012 Sep 15;434(1-2):122-32. doi: 10.1016/j.ijpharm.2012.05.072. Epub 2012 Jun 5.

PMID:
22677418
14.

In situ controlled crystallization as a tool to improve the dissolution of Glibenclamide.

Elkordy AA, Jatto A, Essa E.

Int J Pharm. 2012 May 30;428(1-2):118-20. doi: 10.1016/j.ijpharm.2012.02.046. Epub 2012 Mar 7.

PMID:
22426322

Supplemental Content

Loading ...
Support Center